Photoselective laser ablation of the prostate: A review of the current 2015 tissue ablation options

Canadian Journal of Urology

Volumn 22, Issue , 2015, Pages 45-52

  Tholomier, Côme ^a   Valdivieso, Roger ^a   Hueber, Pierre Alain ^a   Zorn, Kevin C ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Ablation; BOO; BPH; HoLAP; Laser; LUTS; Outcomes; Photovaporization; Prostate; PVP; Surgery; ThuLAP

Indexed keywords

AGED; BLOOD LOSS, SURGICAL; COMPARATIVE STUDY; FOLLOW UP; HUMAN; LOW LEVEL LASER THERAPY; MALE; MINIMALLY INVASIVE SURGERY; OPERATION DURATION; PRACTICE GUIDELINE; PROCEDURES; PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SOLID STATE LASER; THERAPEUTIC USE; TREATMENT OUTCOME; VERY ELDERLY; VOLATILIZATION;

AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; FOLLOW-UP STUDIES; HUMANS; LASER THERAPY; LASERS, SOLID-STATE; MALE; MINIMALLY INVASIVE SURGICAL PROCEDURES; OPERATIVE TIME; PRACTICE GUIDELINES AS TOPIC; PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VOLATILIZATION;

EID: 84981240759     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Oelke M, Bachmann A, Descazeaud A et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2013;64(1):118-140.
2. Fraundorfer MR, Gilling PJ. Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 1998;33(1):69-72.
3. Lowrance WT, Southwick A, Maschino AC, Sandhu JS. Contemporary practice patterns of endoscopic surgical management for benign prostatic hyperplasia among urologists in the United States. J Urol 2013;189(5):1811-1816.
4. Hueber PA, Zorn KC. Canadian trend in surgical management of benign prostatic hyperplasia and laser therapy from 2007-2008 to 2011-2012. Can Urol Assoc J 2013;7(9-10):E582-E586.
5. Peyronnet B, Cornu JN, Roupret M, Bruyere F, Misrai V. Trends in the use of the GreenLight laser in the surgical management of benign prostatic obstruction in France over the past 10 years. Eur Urol 2015;67(6):1193-1195.
6. McVary KT, Roehrborn CG, Avins AL et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 2011;185(5):1793-1803.
7. Gratzke C, Bachmann A, Descazeaud A et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2015;67(6):1099-1109.
8. Herrmann TR, Liatsikos EN, Nagele U, Traxer O, Merseburger AS, EAU Guidelines Panel on Lasers Technologies. EAU guidelines on laser technologies. Eur Urol 2012;61(4):783-795.
9. Bach T, Muschter R, Sroka R et al. Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol 2012;61(2):317-325.
10. Te AE. The next generation in laser treatments and the role of the GreenLight high-performance system laser. Rev Urol 2006;8(Suppl 3):S24-S30.
11. Nazif OA, Teichman JM, Glickman RD, Welch AJ. Review of laser fibers: a practical guide for urologists. J Endourol 2004;18(9): 818-829.
12. Hermanns T, Sulser T, Fatzer M et al. Laser fibre deterioration and loss of power output during photo-selective 80-w potassium-titanyl-phosphate laser vaporisation of the prostate. Eur Urol 2009;55(3):679-685.
13. Issa MM. The evolution of laser therapy in the treatment of benign prostatic hyperplasia. Rev Urol 2005;7(Suppl 9):S15-S22.
14. Westenberg A, Gilling P, Kennett K, Frampton C, Fraundorfer M. Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol 2004;172(2):616-619.
15. Tan AH, Gilling PJ. Holmium laser prostatectomy. BJU Int 2003;92(6):527-530.
16. Mottet N, Anidjar M, Bourdon O et al. Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol 1999;13(2):127-130.
17. Tan AH, Gilling PJ, Kennett KM, Fletcher H, Fraundorfer MR. Long-term results of high-power holmium laser vaporization (ablation) of the prostate. BJU Int 2003;92(7):707-709.
18. Jayadevan R, Stensland K, Baldwin G, Ali A, Hall S, Palese M. MP71-03 comparison of transurethral resection of prostate, PlasmaButtonTM transurethral vaporization of prostate, GreenLightTM 180-W XPS photoselective vaporization of prostate, and Versapulse® 100-W holmium laser ablation of prostate. J Urol 191(4):e790.
19. Elshal AM, Elmansy HM, Elhilali MM. Two laser ablation techniques for a prostate less than 60 mL: lessons learned 70 months after a randomized controlled trial. Urology 2013;82(2):416-422.
20. Elmansy HM, Elzayat E, Elhilali MM. Holmium laser ablation versus photoselective vaporization of prostate less than 60 cc: longterm results of a randomized trial. J Urol 2010;184(5):2023-2028.
21. Madersbacher S, Lackner J, Brossner C et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23, 123 cases. Eur Urol 2005;47(4):499-504.
22. Pariser JJ, Famakinwa OJ, Pearce SM, Chung DE. High-power thulium laser vaporization of the prostate: short-term outcomes of safety and effectiveness. J Endourol 2014;28(11):1357-1362.
23. Vargas C, Garcia-Larrosa A, Capdevila S, Laborda A. Vaporization of the prostate with 150-w thulium laser: complications with 6-month follow-up. J Endourol 2014;28(7):841-845.
24. Bach T, Muschter R, Sroka R et al. Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol 2012;61(2):317-325.
25. Muir G, Gomez F, Choi B, Erol A, Carmona L, Negro C. Multicentre prospective study of the Evolve: Dual 150W laser for bladder outflow obstruction: preliminary results. Urology 2011;78 (Suppl 3A):S59.
26. Wezel F, Wendt-Nordahl G, Huck N et al. New alternatives for laser vaporization of the prostate: experimental evaluation of a 980-, 1, 318-and 1, 470-nm diode laser device. World J Urol 2010;28(2):181-186.
27. Al-Ansari A, Younes N, Sampige VP et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 2010; 58(3):349-355.
28. Chiang PH, Chen CH, Kang CH, Chuang YC. GreenLight HPS laser 120-W versus diode laser 200-W vaporization of the prostate: comparative clinical experience. Lasers Surg Med 2010; 42(7):624-629.
29. Ruszat R, Seitz M, Wyler SF et al. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W highintensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int 2009;104(6):820-825.
30. Shaker HS, Shoeb MS, Yassin MM, Shaker SH. Quartz head contact laser fiber: a novel fiber for laser ablation of the prostate using the 980 nm high power diode laser. J Urol 2012;187(2):575-579.
31. Shaker H, Alokda A, Mahmoud H. The Twister laser fiber degradation and tissue ablation capability during 980-nm high-power diode laser ablation of the prostate. A randomized study versus the standard side-firing fiber. Lasers Med Sci 2012; 27(5):959-963.
32. Zorn KC, Liberman D. GreenLight 180W XPS photovaporization of the prostate: how I do it. Can J Urol 2011;18(5):5918-5926.
33. Hamann MF, Naumann CM, Seif C, van der Horst C, Junemann KP, Braun PM. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up. Eur Urol 2008;54(4):902-907.
34. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006;20(8):580-585.
35. Eken A, Soyupak B, Acil M, Arpaci T, Akbas T. Safety, efficacy and outcomes of the new GreenLight XPS 180W laser system compared to the GreenLight HPS 120W system for the treatment of benign prostatic hyperplasia in a prospective nonrandomized single-centre study. Can Urol Assoc J 2015;9(1-2):e56-e60.
36. Ruszat R, Seitz M, Wyler SF et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008;54(4):893-901.
37. Hai MA. Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population. Urology 2009;73(4): 807-810.
38. Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU Int 1999;83(3):227-237.
39. Thomas JA, Tubaro A, Barber N et al. A Multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Euro Urol 2015 Epub ahead of print.
40. Bachmann A, Tubaro A, Barber N et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol 2015;193(2):570-578.
41. Plata M, Trujillo CG, Dominguez C et al. Photoselective vaporization with KTP 180-W Green laser for the treatment of lower urinary symptoms secondary to benign prostatic enlargement: effectiveness and safety at midterm follow-up. J Endourol 2015. Epub ahead of print.
42. Chung DE, Wysock JS, Lee RK et al. Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia. J Urol 2011;186(3):977-981.
43. Ruszat R, Wyler S, Forster T et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007;51(4):1031-1038; discussion 8-41.
44. Bachmann A, Muir GH, Collins EJ et al. 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol 2012;61(3):600-607.
45. Sandhu JS, Ng CK, Gonzalez RR et al. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005;19(10):1196-1198.
46. Hueber PA, Liberman D, Ben-Zvi T et al. 180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parameters. Urology 2013;82(5):1108-1113.
47. Brunken C, Seitz C, Woo HH. A systematic review of experience of 180-W XPS GreenLight laser vaporisation of the prostate in 1640 men. BJU Int 2015;116(4):531-537.
48. Hueber PA, Bienz MN, Valdivieso R et al. Photoselective vaporization of the prostate for benign prostatic hyperplasia using the 180 Watt system: multicenter study of the impact of prostate size on safety and outcomes. J Urol 2015;194(2):462-469.
49. Elshal AM, Elkoushy MA, El-Nahas AR et al. GreenLight laser (XPS) photoselective vapo-enucleation versus holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic hyperplasia: a randomized controlled study. J Urol 2015;193(3):927-934.
50. Kim Y, Seong YK, Kim IG, Han BH. Twelve-month follow-up results of photoselective vaporization of the prostate with a 980-nm diode laser for treatment of benign hyperplasia. Korean J Urol 2013;54(10):677-681.
51. Chen CH, Chiang PH, Chuang YC et al. Preliminary results of prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-W high-intensity diode laser. Urology 2010;75(3):658-663.